Cargando…

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease

There are nearly 50 million people with Alzheimer's disease (AD) worldwide and currently no disease modifying treatment is available. AD is characterized by deposits of Amyloid-β (Aβ), neurofibrillary tangles, and neuroinflammation, and several drug discovery programmes studies have focussed on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumner, Isabelle L., Edwards, Ross A., Asuni, Ayodeji A., Teeling, Jessica L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924811/ https://www.ncbi.nlm.nih.gov/pubmed/29740272 http://dx.doi.org/10.3389/fnins.2018.00254

Ejemplares similares

Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer’s Disease: Insights From Preclinical Models, Clinical Data, and Future Directions
por: Clement, Amalie, et al.
Publicado: (2020)

New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
por: Fuller, James P., et al.
Publicado: (2014)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
por: Xin, Jia-yan, et al.
Publicado: (2021)

Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease
por: Carare, Roxana Octavia, et al.
Publicado: (2013)

The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
por: Viola, Kirsten L., et al.
Publicado: (2022)

Modifiable Risk Factors for Alzheimer’s Disease
por: Edwards III, George A., et al.
Publicado: (2019)

Special Issue “Antibody Engineering for Cancer Immunotherapy”
por: Crescioli, Silvia, et al.
Publicado: (2022)

Propionate and Alzheimer’s Disease
por: Killingsworth, Jessica, et al.
Publicado: (2021)

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
por: Lin, Rong-Rong, et al.
Publicado: (2021)

Systemic Inflammation Accelerates Changes in Microglial and Synaptic Markers in an Experimental Model of Chronic Neurodegeneration
por: Chouhan, Joe K., et al.
Publicado: (2022)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
por: La Morgia, Chiara, et al.
Publicado: (2017)

Addressing Disparities in Alzheimer's Disease and African-American Participation in Research: An Asset-Based Community Development Approach
por: Green-Harris, Gina, et al.
Publicado: (2019)

Pathogenic tau does not drive activation of the unfolded protein response
por: Pitera, Aleksandra P., et al.
Publicado: (2019)

The immunotherapy of Alzheimer's disease
por: Weksler, Marc E
Publicado: (2004)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Reversal of Cognitive Impairment in gp120 Transgenic Mice by the Removal of the p75 Neurotrophin Receptor
por: Speidell, Andrew, et al.
Publicado: (2019)

CoreNEURON : An Optimized Compute Engine for the NEURON Simulator
por: Kumbhar, Pramod, et al.
Publicado: (2019)

Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice
por: Pankiewicz, Joanna E, et al.
Publicado: (2014)

Alzheimer's Disease and Anesthesia
por: Papon, Marie-Amélie, et al.
Publicado: (2011)

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: DiFrancesco, Jacopo C., et al.
Publicado: (2015)

Retinal Vasculopathy in Alzheimer’s Disease
por: Shi, Haoshen, et al.
Publicado: (2021)

Analysis of the Hippocampal Proteome in ME7 Prion Disease Reveals a Predominant Astrocytic Signature and Highlights the Brain-restricted Production of Clusterin in Chronic Neurodegeneration
por: Asuni, Ayodeji A., et al.
Publicado: (2014)

Differential Circulating Levels of Naturally Occurring Antibody to α-Synuclein in Parkinson’s Disease Dementia, Alzheimer’s Disease, and Vascular Dementia
por: Wang, Jian, et al.
Publicado: (2020)

Chronic stress induces NPD‐like behavior in APPPS1 and WT mice with subtle differences in gene expression
por: Clement, Amalie, et al.
Publicado: (2021)

Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
por: Yu, Lei, et al.
Publicado: (2021)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Editorial: The Alzheimer's Disease Challenge
por: Alexiou, Athanasios, et al.
Publicado: (2019)

Music as a Mnemonic to Learn Gesture Sequences in Normal Aging and Alzheimer’s Disease
por: Moussard, Aline, et al.
Publicado: (2014)

Antibody variable region engineering for improving cancer immunotherapy
por: Lou, Hantao, et al.
Publicado: (2022)

Immunotherapy for Alzheimer’s disease: hoops and hurdles
por: Lemere, Cynthia A
Publicado: (2013)

Inflammatory process in Alzheimer's Disease
por: Meraz-Ríos, Marco A., et al.
Publicado: (2013)

Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's Disease
por: Trebeschi, Stefano, et al.
Publicado: (2016)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Local Sleep and Alzheimer’s Disease Pathophysiology
por: Mander, Bryce A.
Publicado: (2020)

Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
por: Díaz-Álvarez, Josefa, et al.
Publicado: (2022)

Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020)

Microglia in Alzheimer's Disease: A Role for Ion Channels
por: Thei, Laura, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hm6eo3hq8k8bgj7hcm8lismjse